Accrued Expenses And Other Current Liabilities (Tables)

3 Months Ended

Mar. 31, 2020

Accrued expenses and other current liabilities as of March 31, 2020 and December 31, 2019 consisted of the following:



	As of
	March 31, 2020		December 31, 2019
Research and development expenses	$	1,873,361	$	920,901
Compensation and benefits	1,413,014		1,591,964
General and administrative	1,035,454		120,056
Sales and marketing	207,950		360,016
Sales returns and allowances	1,361,410		2,284,175
Medicaid rebates	95,410		118,271
Other	207,606		244,869
Total accrued expenses and other current liabilities	$	6,194,205	$	5,640,252